Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 1
2009 2
2011 3
2012 7
2013 8
2014 15
2015 10
2016 15
2017 15
2018 19
2019 19
2020 16
2021 22
2022 12
2023 18
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

167 results

Results by year

Filters applied: . Clear all
Page 1
An overview of meningiomas.
Buerki RA, Horbinski CM, Kruser T, Horowitz PM, James CD, Lukas RV. Buerki RA, et al. Among authors: lukas rv. Future Oncol. 2018 Sep;14(21):2161-2177. doi: 10.2217/fon-2018-0006. Epub 2018 Aug 7. Future Oncol. 2018. PMID: 30084265 Free PMC article. Review.
Immune and genomic correlates of response to anti-PD-1 immunotherapy in glioblastoma.
Zhao J, Chen AX, Gartrell RD, Silverman AM, Aparicio L, Chu T, Bordbar D, Shan D, Samanamud J, Mahajan A, Filip I, Orenbuch R, Goetz M, Yamaguchi JT, Cloney M, Horbinski C, Lukas RV, Raizer J, Rae AI, Yuan J, Canoll P, Bruce JN, Saenger YM, Sims P, Iwamoto FM, Sonabend AM, Rabadan R. Zhao J, et al. Among authors: lukas rv. Nat Med. 2019 Mar;25(3):462-469. doi: 10.1038/s41591-019-0349-y. Epub 2019 Feb 11. Nat Med. 2019. PMID: 30742119 Free PMC article.
ERK1/2 phosphorylation predicts survival following anti-PD-1 immunotherapy in recurrent glioblastoma.
Arrieta VA, Chen AX, Kane JR, Kang SJ, Kassab C, Dmello C, Zhao J, Burdett KB, Upadhyayula PS, Lee-Chang C, Shilati J, Jaishankar D, Chen L, Gould A, Zhang D, Yuan J, Zhao W, Ling X, Burks JK, Laffleur B, Amidei C, Bruce JN, Lukas RV, Yamaguchi JT, Cieremans D, Rothschild G, Basu U, McCord M, Brat DJ, Zhang H, Cooper LAD, Zhang B, Sims P, Cloughesy TF, Prins R, Canoll P, Stupp R, Heimberger AB, Horbinski C, Iwamoto FM, Rabadan R, Sonabend AM. Arrieta VA, et al. Among authors: lukas rv. Nat Cancer. 2021 Dec;2(12):1372-1386. doi: 10.1038/s43018-021-00260-2. Epub 2021 Nov 29. Nat Cancer. 2021. PMID: 35121903 Free PMC article.
Repeated blood-brain barrier opening with an implantable ultrasound device for delivery of albumin-bound paclitaxel in patients with recurrent glioblastoma: a phase 1 trial.
Sonabend AM, Gould A, Amidei C, Ward R, Schmidt KA, Zhang DY, Gomez C, Bebawy JF, Liu BP, Bouchoux G, Desseaux C, Helenowski IB, Lukas RV, Dixit K, Kumthekar P, Arrieta VA, Lesniak MS, Carpentier A, Zhang H, Muzzio M, Canney M, Stupp R. Sonabend AM, et al. Among authors: lukas rv. Lancet Oncol. 2023 May;24(5):509-522. doi: 10.1016/S1470-2045(23)00112-2. Lancet Oncol. 2023. PMID: 37142373 Clinical Trial.
Paraneoplastic epilepsy.
Serafini A, Lukas RV, VanHaerents S, Warnke P, Tao JX, Rose S, Wu S. Serafini A, et al. Among authors: lukas rv. Epilepsy Behav. 2016 Aug;61:51-58. doi: 10.1016/j.yebeh.2016.04.046. Epub 2016 Jun 12. Epilepsy Behav. 2016. PMID: 27304613 Review.
Nonmalignant Brain Tumors.
Lukas RV, Mrugala MM. Lukas RV, et al. Continuum (Minneap Minn). 2020 Dec;26(6):1495-1522. doi: 10.1212/CON.0000000000000942. Continuum (Minneap Minn). 2020. PMID: 33273170 Review.
Next Steps for Immunotherapy in Glioblastoma.
Cao TQ, Wainwright DA, Lee-Chang C, Miska J, Sonabend AM, Heimberger AB, Lukas RV. Cao TQ, et al. Among authors: lukas rv. Cancers (Basel). 2022 Aug 20;14(16):4023. doi: 10.3390/cancers14164023. Cancers (Basel). 2022. PMID: 36011015 Free PMC article. Review.
Challenging Cases in Neuro-Oncology.
Lukas RV, Mrugala MM, Lesniak MS, Chandler JP. Lukas RV, et al. Semin Neurol. 2022 Dec;42(6):752-757. doi: 10.1055/a-1985-7157. Epub 2022 Nov 23. Semin Neurol. 2022. PMID: 36417993 Review.
What is New in Neuro-oncology?
Thakkar JP, Prabhu VC, Peters KB, Lukas RV. Thakkar JP, et al. Among authors: lukas rv. Neurol Clin. 2021 Feb;39(1):163-179. doi: 10.1016/j.ncl.2020.09.009. Epub 2020 Nov 7. Neurol Clin. 2021. PMID: 33223081 Review.
Paraneoplastic nerve hyperexcitability.
Liebenthal JA, Rezania K, Nicholas MK, Lukas RV. Liebenthal JA, et al. Among authors: lukas rv. Neurol Res. 2015 Jun;37(6):553-9. doi: 10.1179/1743132815Y.0000000006. Epub 2015 Jan 16. Neurol Res. 2015. PMID: 25591423 Review.
167 results